Extensive destruction of the eyeball by invasion of basal cell carcinoma of the eyelid.
BACKGROUND
Eyeball destruction caused by invasion of basal cell carcinoma of the eyelid.


METHODS
A 100-year-old woman showed extensive eyeball destruction caused by the invasion of basal cell carcinoma of the eyelid. Complete ophthalmologic examinations, including computed tomographic (CT) scans of the orbit, were performed. The patient underwent incisional biopsy and bacteriological examination of the exudate from the lesion.


METHODS
Orbital CT scan showed a mass in the extraconal space of the right orbit, with extension to the adjacent sinus cavity without brain involvement. The remnant of the eyeball was posteriorly displaced. Pseudomonas aeruginosa was identified by culture examination of the exudate. Histological study of the biopsy specimen showed basal cell carcinoma of the noduloulcerative type.


CONCLUSIONS
Basal cell carcinoma of the eyelid had caused severe periorbital and eyeball destruction.
Jeong
S
S
Department of Ophthalmology, Chonnam University Medical School, Chonnam Research Institute of Medical Science, Kwangju, South Korea.
Yang
K J
KJ
Park
Y G
YG
D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents; D002280:Basal Cell Carcinoma / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D015818:Eye Infections, Bacterial / Q000175:diagnosis; D005142:Eyelid Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology*; D005260:Female; D006801:Humans; D009361:Neoplasm Invasiveness; D009918:Orbital Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology*; D010255:Paranasal Sinus Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology*; D011552:Pseudomonas Infections / Q000175:diagnosis; D014057:Tomography, X-Ray Computed
D000900:Anti-Bacterial Agents